Allogeneic non-myeloablative stem cell transplantation for the patients with heavily pre-treated refractory lymphoma

Haematologica

Volumn 86, Issue 10, 2001, Pages 1114-1115

  Le, J H ^a   Kang, Y K ^a   Lee, J S ^a   Kim, W K ^a   Lee, K H ^a  

^a Asan Medical Center   (South Korea)

Author keywords

Lymphoma; Non myeloablative; Stem cell transplantation

Indexed keywords

AMELOGENIN; BUSULFAN; CYCLOSPORIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; METHYLPREDNISOLONE; MYELOABLATIVE AGENT; THYMOCYTE ANTIBODY;

ADULT; ALLOGRAFT; ARTICLE; CHIMERA; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LYMPHOMA; MALE; POLYMERASE CHAIN REACTION; PROPHYLAXIS; RISK BENEFIT ANALYSIS; STEM CELL TRANSPLANTATION; TANDEM REPEAT;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; SALVAGE THERAPY; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0034761665     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation
2. Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies
3. High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma
4. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma
5. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
6. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
7. Hematopoietic cell transplantation in older patients with hematologic malignancies: Replacing high-dose cytotoxic therapy with graft-versus-tumor effects
8. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma
9. Melphalan and purine analog-containing preparative regimens: Reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation
10. Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease